Literature DB >> 6477929

Immunoreactive pancreatic colipase, lipase and phospholipase A2 in human plasma and urine from healthy individuals.

B Sternby, B Akerström.   

Abstract

A radioimmunoassay for each of the human pancreatic proteins (colipase, lipase and phospholipase A2) is described. Determinations of the mean concentration of each protein in plasma and urine from healthy individuals were carried out with the radioimmunoassays. The values obtained in plasma were 0.5 nM (5.3 micrograms/l), 0.6 nM (32 micrograms/l) and 0.3 nM (4.3 micrograms/l) for colipase, lipase and phospholipase A2, respectively. In urine, the corresponding values were found to be 0.2 nM (2.4 micrograms/l), 0.09 nM (4.4 micrograms/l) and less than 0.017 nM (0.2 micrograms/l). No physical interaction between any of the three proteins and the lipid particles of plasma was demonstrated by centrifugation experiments or gel filtration. Gel filtration of plasma depleted of fat by centrifugation showed the proteins only in their monomeric form. The corresponding porcine proteins displayed a binding to antibodies against the human proteins, but with a lower affinity than the homologous interactions. The binding was weak but could differentiate between the porcine proforms and activated ones, i.e., procolipase and colipase87.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6477929     DOI: 10.1016/0167-4838(84)90201-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  The diagnostic value of serum pancreatic phospholipase A2 (PLA2) in pancreatic diseases.

Authors:  M Kitagawa; T Hayakawa; T Kondo; T Shibata; Y Sakai; H Sobajima; H Ishiguro; Y Nakae
Journal:  Gastroenterol Jpn       Date:  1991-02

2.  Urinary phospholipase A2 excretion in chronic pancreatic diseases.

Authors:  C Fabris; D Basso; M P Panozzo; G Del Favero; T Meggiato; M Plebani; C Ferrara; P Fogar; M Zaninotto; R Naccarato
Journal:  Int J Pancreatol       Date:  1992-06

3.  Time-resolved fluoroimmunoassay of pancreatic phospholipase A2.

Authors:  T J Nevalainen; J U Eskola
Journal:  Klin Wochenschr       Date:  1989-02-01

4.  Hyperphospholipasemia A2 in human volunteers challenged with intravenous endotoxin.

Authors:  W Pruzanski; D W Wilmore; A Suffredini; G D Martich; A G Hoffman; J L Browning; E Stefanski; B Sternby; P Vadas
Journal:  Inflammation       Date:  1992-10       Impact factor: 4.092

5.  Compartmental heterogeneity of soluble phospholipases A.

Authors:  P Vadas; W Pruzanski; E Stefanski; B Sternby
Journal:  Inflammation       Date:  1990-04       Impact factor: 4.092

6.  Radioimmunoassay for human pancreatic lipase in acute pancreatitis.

Authors:  I M Roberts; D Mercer
Journal:  Dig Dis Sci       Date:  1987-04       Impact factor: 3.199

7.  Fatty acid control of lipoprotein lipase: a link between energy metabolism and lipid transport.

Authors:  J Peterson; B E Bihain; G Bengtsson-Olivecrona; R J Deckelbaum; Y A Carpentier; T Olivecrona
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

8.  Carboxyl ester lipase in human tissues and in acute pancreatitis.

Authors:  H J Aho; B Sternby; M Kallajoki; T J Nevalainen
Journal:  Int J Pancreatol       Date:  1989-09

9.  Rat pancreatic phospholipase A2. Purification, localization, and development of an enzyme immunoassay.

Authors:  P T Kortesuo; A J Hietaranta; M Jämiä; P Hirsimäki; T J Nevalainen
Journal:  Int J Pancreatol       Date:  1993-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.